Development of sensory neuropathy in streptozotocin-induced diabetic mice

Brain and Behavior

Volumn 3, Issue 1, 2013, Pages 35-41

  Murakami, Tatsufumi ^a   Iwanaga, Takayuki ^b   Ogawa, Yoshinao ^b   Fujita, Yoshiaki ^c   Sato, Eiji ^b   Yoshitomi, Hironori ^b   Sunada, Yoshihide ^a   Nakamura, Akihiro ^c  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b FUKUYAMA UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Diabetic sensory neuropathy; Impaired maturation; Sensory conduction velocity; STZ induced diabetic mice; Unmyelinated fiber atrophy

Indexed keywords

INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; HISTOPATHOLOGY; HYPOALGESIA; MALE; MOUSE; MYELIN SHEATH; MYELINATED NERVE; NERVE CONDUCTION; NERVE FIBER; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NOCICEPTION; NONHUMAN; NONMYELINATED NERVE; PRIORITY JOURNAL; SENSORY NEUROPATHY; STREPTOZOCIN DIABETES;

EID: 84883198144     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.111     Document Type: Article

References (24)

1. Christianson, J. A., J. T. Riekhof, and D. E. Wright 2003a. Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp. Neurol. 179:188-199.
2. Christianson, J. A., J. M. Ryals, K. E. McCarson, and D. E. Wright 2003b. Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice. J. Pain 4:493-504.
3. Christianson, J. A., J. M. Ryals, M. S. Johnson, R. T. Dobrowsky, and D. E. Wright 2007. Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 145:303-313.
4. Dobretsov, M., D. Romanovsky, and J. R. Stimers 2007. Early diabetic neuropathy: triggers and mechanisms. World J. Gastroenterol. 13:175-191.
5. Fraher, J. P., D. O'Leary, M. A. Moran, M. Cole, R. H. King, and P. K. Thomas 1990. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 1. Normal animals. Acta Neuropathol. 79:364-374.
6. Johnson, M. S., J. M. Ryals, and D. E. Wright 2008. Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy. Pain 140:35-47.
7. Kamiya, H., W. Zhang, and A. A. Sima 2009. Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetes. Exp. Diabetes Res. 2009:793281.
8. Kennedy, J. M., and D. W. Zochodne 2000. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain 123:2118-2129.
9. Kessler, J. A. 2009. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy. Ann. Neurol. 65:362-364.
10. Kurokawa, K., D. F. de Almeida, Y. Zhang, C. D. Hébert, J. G. Page, K. M. Schweikart, et al. 2004. Sensory nerve conduction of the plantar nerve compared with other nerve conduction tests in rats. Clin. Neurophysiol. 115:1677-1682.
11. Llewelyn, J. G., D. R. Tomlinson, and P. K. Thomas 2005. Diabetic neuropathies. Pp. 1951-1991 in P. J. Dyck and P. K. Thomas, eds. Peripheral neuropathies. 4th ed. Elsevier, Philadelphia, PA.
12. Murakami, T., M. Arai, Y. Sunada, and A. Nakamura 2006. VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice. J. Gene Med. 8:773-781.
13. Murakami, T., Y. Imada, M. Kawamura, T. Takahashi, Y. Fujita, E. Sato, et al. 2011. Placental growth factor-2 gene transfer by electroporation restores diabetic sensory neuropathy in mice. Exp. Neurol. 227:195-202.
14. Obrosova, I. G. 2009. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 6:638-647.
15. Pittenger, G., and A. Vinik 2003. Nerve growth factor and diabetic neuropathy. Exp. Diabesity Res. 4:271-285.
16. Randall, L. O., and J. J. Selitto 1957. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 4:409-419.
17. Robertson, D. M., and A. A. Sima 1980. Diabetic neuropathy in the mutant mouse [C57BL/ks(db/db)]: a morphometric study. Diabetes 29:60-67.
18. Ropper, A. H., K. C. Gorson, C. L. Gooch, D. H. Weinberg, A. Pieczek, J. H. Ware, et al. 2009. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann. Neurol. 65:386-393.
19. Sima, A. A., and D. M. Robertson 1979. Peripheral neuropathy in the diabetic mutant mouse. An ultrastructural study. Lab. Invest. 40:627-632.
20. Thomas, P. K., J. P. Fraher, D. O'Leary, M. A. Moran, M. Cole, and R. H. King 1990. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 2. Effect of streptozotocin-induced diabetes. Acta Neuropathol. 79:375-386.
21. Tomlinson, D. R., and N. J. Gardiner 2008. Glucose neurotoxicity. Nat. Rev. Neurosci. 9:36-45.
22. Yagihashi, S., M. Kamijo, Y. Ido, and D. J. Mirrlees 1990. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats. Diabetes 39:690-696.
23. Yagihashi, S., S. Yamagishi, R. Wada, M. Baba, T. C. Hohman, C. Yabe-Nishimura, et al. 2001. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain 124:2448-2458.
24. Zochodne, D. W. 2007. Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms. Muscle Nerve 36:144-166.